- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01288001
Study of Evaluating the Duration of Efficacy of One Intra Articular Injection of Sodium Hyaluronate 2.0% in Patients With Painful Osteoarthritis of the Knee
November 20, 2012 updated by: TRB Chemedica
A Pilot, Open, Randomised, Controlled, add-on Study Evaluating the Duration of Efficacy of One Intra Articular Injection of Sodium Hyaluronate 2.0% in Patients With Painful Osteoarthritis of the Knee
A pilot, open, randomised, controlled, add-on study evaluating the duration of efficacy of one intra articular injection of sodium hyaluronate 2.0% in patients with painful osteoarthritis of the knee
Study Overview
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bangkok
-
Bangkoknoi, Bangkok, Thailand, 10700
- Siriraj Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
38 years to 68 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients of both genders between 40 and 70 years of age;
- Primary tibiofemoral osteoarthritis of the knee according to American College of Rheumatology criteria;
- Pain ≥ 4 on a 10 point scale for at least two out of five subscores of the WOMAC Section A at baseline;
- Radiologically ascertained grade II or III severity knee osteoarthritis on the Kellgren-Lawrence scale;
- Having given signed informed consent.
Exclusion Criteria:
Secondary knee osteoarthritis, including:
- septic arthritis;
- inflammatory joint disease;
- gout;
- recurrent episodes of pseudogout;
- Paget's disease of bone;
- articular fracture;
- ochronosis;
- acromegaly;
- haemochromatosis;
- Wilson's disease;
- primary osteochondromatosis.
- Clinical signs of acute flare (pain, warm, erythema, effusion of signal knee) at baseline;
- Axial deviation > 15 degrees in valgus or varus on a standing X-ray;
- Clinically significant medio-lateral or antero-posterior instability;
- Rapid destructive arthritis, evolving arthritis requiring surgery within the coming year;
- Significant injury to the signal knee within 6 months prior to baseline;
- Complete loss of range of motion;
- Painful knee conditions other than osteoarthritis (e.g., Sudeck's atrophy, intra-articular neoplasm, villonodular synovitis);
- Necrosis of one of the femur condyles;
- History or evidence of gout, chondrocalcinosis;
- Peripheral neuropathy;
Concomitant rheumatic disease:
- fibromyalgia;
- rheumatoid arthritis;
- collagen diseases;
- psoriatic arthritis and other seronegative spondylarthropathies (e.g., ankylosing spondylitis);
- metabolic and crystal-induced arthropathies;
- other osteopathies.
- Contraindications to intra-articular injection according to investigator's judgement (e.g., local infection at injection site, generalised infection with possible bacteraemia);
- Skin disease in the area of injection;
- Severe coagulopathy, ongoing anticoagulation therapy;
- Accompanying OA of the hip of sufficient severity to interfere with the assessment of the signal knee;
- Disease of spine, hip or other lower extremity joints of sufficient degree to affect assessment of the signal knee;
- Poor general health interfering with compliance or assessment;
- Concomitant disease/ailment other than knee OA requiring the regular use of the patient's normal analgesic medicine;
- Initiation of chronic treatment with antihistaminics, glucocorticoids, antidepressants or tranquilisers, within less than 3 months prior to baseline;
- Use of assistive devices other than a cane (walking stick);
- Surgery of the signal knee other than arthroscopy;
- Arthroscopy of the signal knee within one year prior to baseline;
- Treatment with symptomatic slow acting drug for OA (SYSADOA, i.e., chondroitin sulfate, diacerein, glucosamine, piascledine), unless the patient has been on a stable dose for at least 4 months prior to baseline;
- Intra-articular depocorticosteroid injection into the signal knee within 3 months prior to baseline;
- Intra-articular SH injection into the signal knee within 6 months prior to baseline;
- Ascertained hypersensitivity to any product used in the study (SH, paracetamol, diclofenac, omeprazole) or to similar compounds;
- Pregnant or lactating female;
- Female of childbearing potential without adequate contraceptive methods;
- Participation in a drug clinical trial within 3 months prior screening;
- Patients who, in the judgement of the investigator, will not comply with the protocol.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Ostenil plus
Patient will get Ostenil plus injection and standard treatment of Osteoarthritis
|
2% Sodium Hyaluronate plus Mannitol injection
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
to evaluate the duration of efficacy of one intra articular injection of Ostenil® Plus in patients with painful osteoarthritis of the knee.
Time Frame: 6 months
|
WOMAC score
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
to evaluate the effects of the study treatment on pain, joint stiffness, joint function and need for analgesic consumption.
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2011
Primary Completion (Actual)
December 1, 2011
Study Completion (Actual)
July 1, 2012
Study Registration Dates
First Submitted
January 31, 2011
First Submitted That Met QC Criteria
January 31, 2011
First Posted (Estimate)
February 2, 2011
Study Record Updates
Last Update Posted (Estimate)
November 21, 2012
Last Update Submitted That Met QC Criteria
November 20, 2012
Last Verified
November 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OSTP-THA-10-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis Patient
-
University of MelbourneCompletedKnee Osteoarthritis | Patient EmpowermentAustralia
-
Tanta UniversityCompletedHip Osteoarthritis | Patient Satisfaction
-
The Catholic University of KoreaUnknownOsteoarthritis, Patient-specific Instruments
-
Technische Universität DresdenActive, not recruitingKnee Osteoarthritis | Knee Arthroplasty | Patient Reported OutcomeGermany
-
Lund UniversityCompletedOsteoarthritis | Patient Education as TopicSweden
-
Karolinska InstitutetRecruitingOsteo Arthritis Knee | Patient Satisfaction | ACL | Graft Failure | Meniscus TearSweden
-
University of AarhusUnknownPatient Engagement | Patient Empowerment | Patient Compliance
-
The University of Texas at ArlingtonAgency for Healthcare Research and Quality (AHRQ)RecruitingPatient Engagement | Patient Empowerment | Patient ActivationUnited States
-
University College of Northern DenmarkRecruitingPain | Osteoarthritis, Knee | Rehabilitation | Patient Reported Outcome Measures | Adults | Recovery of Function | Treatment Outcome | Knee Brace | Outcome Assessment (Health Care)Denmark
-
University of California, San DiegoPatient-Centered Outcomes Research Institute; University of Massachusetts,... and other collaboratorsCompletedPatient Engagement | Physician-Patient Relations | Physician's Role | Patient ActivationUnited States
Clinical Trials on Ostenil plus
-
TRB Chemedica AGRecruiting
-
TRB ChemedicaCompleted
-
Regen Lab SAUnknown
-
TRB Chemedica AGActive, not recruiting
-
TRB Chemedica AGRecruiting
-
TRB Chemedica AGCompleted
-
Wrightington, Wigan and Leigh NHS Foundation TrustTRB ChemedicaRecruitingLateral Epicondylitis | Tennis Elbow | Elbows TendonitisUnited Kingdom
-
Technical University of MunichCompleted
-
Fortius ClinicUnknownNon-Insertional Achilles Tendinopathy | Plantaris Friction SyndromeUnited Kingdom
-
TRB Chemedica AGCompleted